Literature DB >> 31135827

An International Perspective on Drugs for Cancer: The Best of Times, the Worst of Times.

Richard Lehman1, Cary P Gross2,3,4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31135827     DOI： 10.1001/jamainternmed.2019.0458

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Error in Byline in: An International Perspective on Drugs for Cancer.

Authors: 
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

Review 2.  An urgent call to raise the bar in oncology.

Authors:  John-John B Schnog; Michael J Samson; Rijk O B Gans; Ashley J Duits
Journal:  Br J Cancer       Date:  2021-08-16       Impact factor: 7.640

3.  Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

Authors:  Yichen Zhang; Huseyin Naci; Anita K Wagner; Ziyue Xu; Yu Yang; Jun Zhu; Jiafu Ji; Luwen Shi; Xiaodong Guan
Journal:  JAMA Netw Open       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.